CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Innovations in CRISPR, TALENs, and next-generation sequencing (NGS ... driven by the growing focus on drug discovery and biologics production. Various biotech firms use synthetic biology technologies ...

Synthetic biology has grown exponentially in less than a decade, with CRISPR gene-editing as the ... living through the early stages of the ‘biotech century’, as economic and social theorist ...

DNA, or deoxyribonucleic acid, is the fundamental building block of life. It carries the genetic instructions that dictate ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

CRISPR Therapeutics (NASDAQ: CRSP) stock climbed 7% after receiving an upgrade from Evercore ISI, shifting from an In Line rating to Outperform. The biotechnology company, known for its CRISPR/Cas9 ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...